New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer

A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows. The drug, a molecular targeted compound called pertuzumab, works by binding to and inhibiting the function of HER2 receptors, interrupting a key pathway that leads to cancer growth.

The study, published in the February 20 issue of the Journal of Clinical Oncology, involved 41 patients with treatment-resistant prostate cancer who had experienced progression of their disease after prior chemotherapy. Patients received the drug every three weeks until disease progression. MRI and CAT scans were used to evaluate the tumors during the period of drug therapy. While no shrinkage of tumors was reported, retrospective analysis showed that survival rate was prolonged to 16.4 months with the drug as compared to a median average of 10.7 months in a historical control group with similar baseline prognostic features.

Advanced prostate cancer is difficult to treat and the drug therapies currently available to these patients have not been very effective, especially in patients whose disease has progressed after chemotherapy treatment, said David B. Agus, M.D., principal investigator of the study and research director of Cedars-Sinais Louis Warschaw Prostate Cancer Center at the Samuel Oschin Comprehensive Cancer Institute. Pertuzumab may offer a new treatment approach for these patients when it is evaluated as a tool to slow not stop or shrink -- tumor growth.

The theory is that by significantly slowing progression of the cancer, patients will experience a good quality of life for a longer period of time, said Agus. Ultimately, we hope drugs like pertuzumab will help us reach the point where cancer can be viewed as a lifetime disease to be managed much like AIDS is looked at now. This would be major shift from the current

Contact: Simi Singer
Cedars-Sinai Medical Center

Page: 1 2 3

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. Early-morning Friday classes may prevent students from getting sloppy on thirsty Thursdays
3. Panel offers guidelines on skin reactions to new class of cancer drugs
4. UK researchers find new class of nontoxic cancer treatments
5. New class of HIV drug attacks previously untargeted enzyme
6. Sleep disturbances affect classroom performance
7. Simple classification can help define and predict limb-threatening diabetic infections
8. World-class Biomedical Research Center to be in West London
9. A new way of classifying addictive drugs
10. Phys ed class more effective when theres more talking
11. W.M. Keck Foundation announces 2006 class of Distinguished Young Scholars in Medical Research

Post Your Comments:
(Date:10/9/2015)... ... , ... Yisrayl Hawkins, Pastor at The House of Yahweh in Abilene, Texas, ... back to the beginning, literally, starting in the book of Genesis. , Yisrayl ... biblical laws were being taught. The letter addresses the many types of illnesses ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Bag ... participants, volunteers, staff, and members of the media at the annual IRONMAN ... participate in the 140.6 mile triathlon, which has taken place in Hawaii every year ...
(Date:10/9/2015)... Washington, D.C. (PRWEB) , ... October 09, 2015 , ... ... airplanes dropped bombs that often did not explode. A very brave group of ... the United Kingdom. As Winston Churchill noted in 1941, “The rapid disposal of unexploded ...
(Date:10/8/2015)... ... , ... Dr. Paul Vitenas, one of the most respected cosmetic surgeons in ... that his Mirror Mirror Beauty Boutique has been honored as one of ... a social network designed just for those in the aesthetics industry. , Aesthetic Everything ...
(Date:10/8/2015)... ... October 08, 2015 , ... Multicultural competencies and spirituality in end-of-life ... Hospital. , The ninth annual event will take place from 8 a.m. to 4 ... 34th Street in Manhattan. This location was chosen to conveniently accommodate the potential large ...
Breaking Medicine News(10 mins):
(Date:10/9/2015)... 2015 Henry Schein , Inc. (NASDAQ: ... care products and services to office-based dental, animal health ... Henry Schein Disaster Relief Hotline is open for dentists, ... issues as a result of the disastrous flooding in ... for all Henry Schein customers is 800-999-9729. ...
(Date:10/9/2015)... Ga. , Oct. 9, 2015  Hi-Tech ... Nutrition products, Contract Manufacturing, and iForce Nutrition ("iForce"), one ... the United States , today announced ... in which Hi-Tech has agreed to acquire iForce. ... arsenal and expand its distribution through iForce,s strong ...
(Date:10/9/2015)... DIEGO , Oct. 9, 2015 Ansun ... (Infectious Disease Society of America ) regarding the compassionate ... transplant patient on a respirator who was co-infected with ... a five-day course of therapy, O 2 requirement ... the patient was able to go off the respirator ...
Breaking Medicine Technology:
Cached News: